Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2008-8-18
pubmed:abstractText
Human TRIM5alpha restricts N-tropic murine leukemia virus (N-MLV) but not B-tropic MLV (B-MLV) infection. Here we study B30.2/SPRY domain mutants of human TRIM5alpha that acquire the ability to inhibit B-MLV infection prior to reverse transcription without losing the ability to restrict N-MLV infection. Remarkably, these mutants gain the ability to decrease the amount of particulate B-MLV capsids in the cytosol of infected cells. In addition, these mutants gain the ability to restrict SIV(mac) and HIV-2 infection. B-MLV and SIV(mac) infections were blocked by the mutant TRIM5alpha proteins prior to reverse transcription. Thus, the range of retroviruses restricted by human TRIM5alpha can be increased by changes in the B30.2/SPRY domain, which also result in the ability to cause premature uncoating of the restricted retroviral capsid.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/18586294-10559316, http://linkedlifedata.com/resource/pubmed/commentcorrection/18586294-10906195, http://linkedlifedata.com/resource/pubmed/commentcorrection/18586294-11027299, http://linkedlifedata.com/resource/pubmed/commentcorrection/18586294-11238863, http://linkedlifedata.com/resource/pubmed/commentcorrection/18586294-12154227, http://linkedlifedata.com/resource/pubmed/commentcorrection/18586294-12368468, http://linkedlifedata.com/resource/pubmed/commentcorrection/18586294-12388705, http://linkedlifedata.com/resource/pubmed/commentcorrection/18586294-12438612, http://linkedlifedata.com/resource/pubmed/commentcorrection/18586294-14985764, http://linkedlifedata.com/resource/pubmed/commentcorrection/18586294-15249685, http://linkedlifedata.com/resource/pubmed/commentcorrection/18586294-15249687, http://linkedlifedata.com/resource/pubmed/commentcorrection/18586294-15280539, http://linkedlifedata.com/resource/pubmed/commentcorrection/18586294-15649369, http://linkedlifedata.com/resource/pubmed/commentcorrection/18586294-15689398, http://linkedlifedata.com/resource/pubmed/commentcorrection/18586294-15709033, http://linkedlifedata.com/resource/pubmed/commentcorrection/18586294-15767395, http://linkedlifedata.com/resource/pubmed/commentcorrection/18586294-15857996, http://linkedlifedata.com/resource/pubmed/commentcorrection/18586294-16140735, http://linkedlifedata.com/resource/pubmed/commentcorrection/18586294-16540544, http://linkedlifedata.com/resource/pubmed/commentcorrection/18586294-16648264, http://linkedlifedata.com/resource/pubmed/commentcorrection/18586294-16650449, http://linkedlifedata.com/resource/pubmed/commentcorrection/18586294-16699044, http://linkedlifedata.com/resource/pubmed/commentcorrection/18586294-16809279, http://linkedlifedata.com/resource/pubmed/commentcorrection/18586294-16912305, http://linkedlifedata.com/resource/pubmed/commentcorrection/18586294-16973579, http://linkedlifedata.com/resource/pubmed/commentcorrection/18586294-17135314, http://linkedlifedata.com/resource/pubmed/commentcorrection/18586294-17316734, http://linkedlifedata.com/resource/pubmed/commentcorrection/18586294-17626085, http://linkedlifedata.com/resource/pubmed/commentcorrection/18586294-17920096, http://linkedlifedata.com/resource/pubmed/commentcorrection/18586294-18166079, http://linkedlifedata.com/resource/pubmed/commentcorrection/18586294-9557668, http://linkedlifedata.com/resource/pubmed/commentcorrection/18586294-9930301
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
1096-0341
pubmed:author
pubmed:issnType
Electronic
pubmed:day
1
pubmed:volume
378
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
233-42
pubmed:dateRevised
2011-9-26
pubmed:meshHeading
pubmed:year
2008
pubmed:articleTitle
A human TRIM5alpha B30.2/SPRY domain mutant gains the ability to restrict and prematurely uncoat B-tropic murine leukemia virus.
pubmed:affiliation
Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Department of Pathology, Division of AIDS, Harvard Medical School, Boston, MA 02115, USA.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural